US Broker Ratings

Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Sector with Stability Amid Market Volatility

Avantor, Inc. (NYSE: AVTR) stands as a significant player in the healthcare sector, navigating the complex landscape of medical instruments and supplies. With a robust market capitalization of $9.14 billion,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Eyeing an 82% Potential Upside Amid Robust Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents a compelling opportunity for investors looking to capitalize on the biotechnology sector’s growth. Based in San Rafael, California, this biotech powerhouse specializes in developing..

argenx SE (ARGX) Stock Analysis: Exploring the Potential Upside and Analyst Ratings

argenx SE (ARGX), a prominent name in the biotechnology sector, is making waves with its innovative therapies targeting autoimmune diseases. Headquartered in the Netherlands, this commercial-stage biopharma company is captivating..

Exelixis, Inc. (EXEL) Stock Analysis: Unlocking a 16% Potential Upside in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has piqued investor interest with a compelling potential upside of 16.02%. Specializing in oncology, Exelixis focuses on the discovery..

Glaukos Corporation (GKOS) Stock Report: Analyzing a 43.53% Potential Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Aliso Viejo, California, this company has carved out a..

Incyte Corporation (INCY): Investor Outlook with a Focus on Growth and Analyst Ratings

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents a compelling opportunity for investors looking to invest in innovative healthcare solutions. With a market capitalization of approximately..

Repligen Corporation (RGEN) Stock Analysis: An Investor’s Guide to a 23.4% Potential Upside

Repligen Corporation (NASDAQ: RGEN) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $8.17 billion, this Massachusetts-based life sciences..

DaVita Inc. (DVA) Stock Analysis: Evaluating a 22% Potential Upside for Healthcare Investors

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector specializing in kidney dialysis services, presents a compelling case for investors seeking exposure to the medical care facilities industry...

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 43% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in medical instruments and supplies, is capturing the attention of investors with its notable upside potential. Currently trading..

GSK plc (GSK) Stock Analysis: Navigating a 3.79% Dividend Yield Amidst Market Challenges

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, is renowned for its extensive portfolio of vaccines and specialty medicines. With a market capitalization of $88.41 billion, this..

Roivant Sciences Ltd. (ROIV) Stock Analysis: An Attractive 24.97% Upside in the Biotech Arena

Roivant Sciences Ltd. (NASDAQ: ROIV), a notable player in the biotechnology sector, is capturing investor attention for its promising growth potential. With a market capitalization of $10.95 billion, the London-based..

Natera, Inc. (NTRA) Investor Outlook: Analyzing the 14.14% Potential Upside in Healthcare Diagnostics

Natera, Inc. (NASDAQ: NTRA), a pioneer in the global diagnostics and research industry, presents an intriguing investment opportunity with a potential upside of 14.14%. With its headquarters in Austin, Texas,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Insights into a Healthcare Pioneer with 4.12% Upside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector specializing in medical devices, offers an intriguing proposition for investors seeking exposure to the life sciences and clinical diagnostics..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating a Healthcare Giant with a Robust 112.85% Return on Equity

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its solid position in the drug manufacturing industry. With a market capitalization of $407.19..

ICON plc (ICLR) Stock Analysis: A Promising 17.90% Upside for Healthcare Investors

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, stands out in the diagnostics and research industry with its innovative approaches to clinical development. Headquartered in Dublin, Ireland,..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 15.93% Potential Upside Amidst Healthcare Sector Dynamics

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the medical distribution sector, offers a compelling investment opportunity with a notable potential upside of 15.93%. As a prominent player in healthcare,..

Charles River Laboratories (CRL): Investor Outlook Reveals Potential 8.68% Upside

Charles River Laboratories International, Inc. (NYSE: CRL) is an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. With a market cap of $8.22 billion, this..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a Dynamic Market with a 4.24% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a significant player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with its current market dynamics. Headquartered in..

Humana Inc. (HUM) Investor Outlook: Exploring a 6.03% Upside Potential Amidst Strong Revenue Growth

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, continues to attract investor attention with its robust revenue growth and potential upside. Headquartered in Louisville, Kentucky, and..

Stryker Corporation (SYK) Stock Analysis: Strong Analyst Consensus and 17.73% Potential Upside

Stryker Corporation (SYK), a leader in the healthcare sector specializing in medical devices, continues to capture investor interest with its robust market presence and promising growth prospects. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds